Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Doximity Inc. (DOCS:NYSE), powered by AI.
Doximity Inc. is currently trading at $20.89. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Doximity Inc. on Alpha Lenz.
Doximity Inc.'s P/E ratio is 17.5.
“Doximity Inc. trades at a P/E of 17.5 (fair value) with strong ROE of 22.5%. 3Y revenue CAGR of 18.4% highlights clear growth momentum.”
Ask for details →Doximity Inc. is a leading digital platform primarily catering to medical professionals. Founded with the ambition of enhancing communication, collaboration, and information exchange within the healthcare community, Doximity provides a comprehensive suite of tools designed to meet the needs of physicians and allied health professionals. One of its core offerings includes a secure social networking platform that allows doctors to connect with peers, share insights, and stay updated on medical news and advancements. Additionally, Doximity offers telehealth services through its app, supporting virtual patient consultations and flexible healthcare delivery. The platform also serves as a career hub, helping healthcare professionals discover job opportunities and navigate their careers more effectively. With such features, Doximity significantly impacts the healthcare sector by fostering a more connected and efficient professional environment. Its presence in the market underscores the growing trend towards digitization in healthcare, underscoring the importance of technology in enhancing productivity and collaboration among medical professionals.
“Doximity Inc. trades at a P/E of 17.5 (fair value) with strong ROE of 22.5%. 3Y revenue CAGR of 18.4% highlights clear growth momentum.”
Ask for details →Doximity Inc. (ticker: DOCS) is a company listed on NYSE in the Healthcare sector (Health Information Services). It has approximately 830 employees. Market cap is $3.9B.
The current price is $20.89 with a P/E ratio of 17.49x and P/B of 3.61x.
ROE is 22.50% and operating margin is 40.34%. Annual revenue is $570M.